Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company that develops life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
The Director, US Brand Strategy & Launch β Schizophrenia will lead the development and execution of marketing strategies and programs for the launch of Neurocrine products in the US. The role will collaborate with cross-functional partners to ensure a successful commercialization in support of business objectives.
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company that develops life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
Neurocrine Biosciences